COMMUNIQUÉS West-GlobeNewswire

BioStem Technologies Selects PCG Advisory Group for Investor Relations and Strategic Communications
17/10/2018
Pompano Beach, FL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation providing innovative technologies with a concentration in [...]
Cue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine to Further the Potential of Immuno-STAT™ Platform in Chronic Infectious Diseases
17/10/2018
Collaboration Expands Platform’s Reach Beyond Cancer and Autoimmune Disease to Address T cell Exhaustion in Chronic Infectious Diseases CAMBRIDGE, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: [...]
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual Psych Congress
17/10/2018
Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will be able to view demonstrations of and purchase the BrainsWay system and OCD helmet at conference booth #109 [...]
CareDx to Announce Third Quarter 2018 Financial Results on November 8, 2018
17/10/2018
BRISBANE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Intra-Cellular Therapies Presents Results from ITI-214 Phase 1/2 Clinical Trial in Patients with Parkinson’s Disease at 2018 American Neurological Association Annual Meeting
17/10/2018
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
IntelGenx Receives Over $1.6 Million from Exercise of Warrants
17/10/2018
SAINT LAURENT, Quebec, Oct. 17, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that, since September 15, 2018, it has received [...]
Clinical Laserthermia Systems (CLS) Signs Exclusive Distribution Agreement with MRI Interventions for USA and Canada
17/10/2018
2-Year Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond their Previously Announced Spine and Neuro License Agreement [...]
Former UnitedHealth Group Cancer Director Dr. Lee Newcomer Joins Cellworks Board of Directors
17/10/2018
Leading Precision Medicine Company Adds to Prestigious Board of Directors, which includes Dr. David Lawrence, Dr. Allen Lichter and Dr. Bill Rutter SAN JOSE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, [...]
aTyr Pharma Presents at American Society of Human Genetics 2018 Meeting
17/10/2018
SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Intensity Therapeutics to Present Preliminary Data from Clinical Study of INT230-6 at Upcoming Medical Conferences
17/10/2018
Posters at European Society for Medical Oncology (ESMO) 2018 Congress and Society for Immunotherapy of Cancer (SITC) 33 rd Annual Meeting to highlight safety of intratumoral INT230-6 in patients with advanced solid [...]
MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery
17/10/2018
Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 (GLOBE NEWSWIRE) -- [...]
MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery
17/10/2018
Under the Terms of the Agreement, MRIC Acquires Worldwide Exclusive Rights to the Platform for Use in Neurosurgery and Spine with CLS as Manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 (GLOBE NEWSWIRE) -- [...]
ADMA Biologics Receives PDUFA Date for RI-002
17/10/2018
Resubmission of Biologics License Application (“BLA”) Reinforces the Company’s Commitment to Commercialize Novel Therapies for Immune Compromised Patients to Address Unmet Medical Needs RAMSEY, N.J. and BOCA RATON, Fla [...]
Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™
17/10/2018
PETALUMA, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of [...]
Amryt Pharma plc: Lojuxta to be reimbursed in France
17/10/2018
17 October 2018 AIM: AMYT ESM: AYP Amryt Pharma plc (“Amryt” or the “Company”) Lojuxta to be reimbursed in France Amryt’s lead commercial product now available in all five of the EU’s largest markets Amryt, a revenue [...]
Aeglea BioTherapeutics Announces New Positive Interim Clinical Data and Improvements in Disease Manifestations for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency
17/10/2018
Pegzilarginase is Effective in Sustainably Lowering Plasma Arginine Levels Clinically Significant Improvements After Eight Doses Included Effects on Mobility and Adaptive Behavior Company to Host Clinical Update [...]
CLS Signs Agreement with Image Guided Therapy to Develop and Commercialize Product for MR-Generated Temperature Monitoring
17/10/2018
FRAMINGHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- CLS AB in Lund, Sweden, with the subsidiary Clinical Laserthermia Systems Americas, Inc . (CLS Americas), today announced it has signed an agreement with Image Guided [...]
NeuroMetrix Reports Q3 2018 Financial Results
17/10/2018
$3.8M GSK Milestone; Improved Operating Performance WALTHAM, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended September 30 [...]
Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering
17/10/2018
Offering Includes Exercise in Full of the Underwriter’s Option to Purchase an Additional 3.3 Million Shares of Common Stock SAN CARLOS, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: [...]

Pages